MR spectroscopy and MR imaging in metabolic myopathies

Neurologic Clinics

Volumn 18, Issue 1, 2000, Pages 35-52

  Argov, Zohar ^a   Arnold, Douglas L ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA;

CALIBRATION; DIAGNOSTIC IMAGING; ENERGY METABOLISM; EXERCISE TOLERANCE; GLYCOGEN STORAGE DISEASE TYPE 5; GLYCOLYSIS; HYPOTHYROIDISM; IMAGE QUALITY; MITOCHONDRIAL MYOPATHY; MUSCLE EXERCISE; MYOPATHY; OXIDATIVE PHOSPHORYLATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVIEW; TISSUE METABOLISM; BRAIN; EXERCISE TEST; HUMAN; METABOLIC DISORDER; METABOLISM; MITOCHONDRIAL ENCEPHALOMYOPATHY; MUSCLE DISEASE; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; BRAIN; ENERGY METABOLISM; EXERCISE TEST; GLYCOLYSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLIC DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MUSCLE, SKELETAL; MUSCULAR DISEASES; NEUROMUSCULAR DISEASES;

EID: 0033621652     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70178-X     Document Type: Article

References (64)

1. Z. Argov W.J. Bank Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders Ann Neurol 30 1991 90
2. Z. Argov W.J. Bank B. Boden Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis: An in vivo study of phosphoglycerate mutase deficiency Arch Neurol 44 1987 614
3. Z. Argov W.J. Bank J. Maris Bioenergetic heterogeneity of human mitochondrial myopathies: Phosphorus magnetic resonance spectroscopy study Neurology 37 1987 257
4. Z. Argov W.J. Bank J. Maris Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy Ann Neurol 22 1987 46
5. Z. Argov W.J. Bank J. Maris Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy Neurology 37 1987 1720
6. Z. Argov W.J. Bank J. Maris Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study Ann Neurol 19 1986 598
7. 31P-MRS study NMR Biomed 9 1996 165
8. Argov Z. De Stefano N. T. Taivassalo Abnormal oxidative metabolism in exercise intolerance of undetermined origin Neuromuscul Disord 7 1997 99
9. Z. Argov D. Nagle U. Giger Muscle bioenergetics in acute glycolytic block: In vivo phosphorus-nuclear magnetic resonance study of iodo-acetate injected rats Eur J Appl Physiol 58 1989 808
10. Z. Argov P.F. Renshaw B. Boden Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats J Clin Invest 81 1988 1695
11. Z. Argov T. Taivassalo De Stefano N. Intracellular phosphates in inclusion body myositis: A 31P magnetic resonance spectroscopy study Muscle Nerve 21 1998 1523
12. 31P-NMR Magn Reson Med 1 1984 307
13. D.L. Arnold D.J. Taylor G.K. Radda Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy Ann Neurol 18 1985 189
14. 31P magnetic resonance spectroscopy in patients affected by migraine with aura Neurology 42 1992 1209
15. B. Barbiroli P. Montagna P. Martinelli Defective brain energy metabolism shown by in vivo 31 P-MR spectroscopy in 28 patients with mitochondrial cytopathies J Cereb Blood Flow Metab 13 1993 469
16. D. Bendahan S. Confort-Gouny Kozak Reiss G. Pi trapping in glycogenolytic pathway can explain transient Pi disappearance during recovery from muscular exercise: A 31P NMR study in the human FEBS Lett 269 1990 402
17. D. Bendahan S. Confort-Gouny G. Kozak-Ribbens 31 P-NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle Biochem Biophys Res Commun 185 1992 16
18. 31P-NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies Neurology 42 1992 1203
19. R.T. Bogusky R.G. Taylor L.J. Anderson McArdle's disease heterozygotes: Metabolic adaptation assessed using 31 P-nuclear magnetic resonance J Clin Invest 77 1986 1881
20. P.J. Bore L. Chan D.G. Gadian Noninvasive pHi measurements of human tissue using 31 P-NMR Kroc Foundation Series 15 1981 527
21. B. Chance S. Eleff W. Bank 31 P-NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle Proc Natl Acad Sci USA 79 1982 7714
22. J. Chen Z. Argov R.E. Kearney Fitting cytosolic ADP recovery after exercise with a step response function Magnetic Resonance in Medicine 41 1999 926 932
23. J.H. Cross D.G. Gadian A. Connelly Proton magnetic resonance spectroscopy studies in lactic acidosis and mitochondrial disorders J Inherit Metab Dis 16 1993 800
24. De Stefano N. Z. Argov P.M. Matthews Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease Muscle Nerve 19 1996 764
25. De Stefano N. P.M. Matthews B. Ford Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders Neurology 45 1995 1193
26. Dubeau F. De Stefano N. P.M. Matthews Investigation of a large kindred with the MELAS syndrome [abstract] Neurology 48 suppl 3 1997 354
27. D. Duboc P. Jehenson Tran Dinh S. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis Neurology 37 1987 663
28. R.H. Edwards M.J. Dawson D.R. Wilkie Clinical use of nuclear magnetic resonance in the investigation of myopathy Lancet 1 1982 725
29. S.M. Eleff P.B. Barker S.J. Blackband Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine Ann Neurol 27 1990 626
30. S. Eleff N.G. Kennaway N.R. Buist 31 P-NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle Proc Natl Acad Sci USA 81 1984 3529
31. J.L. Fleckenstein C.D. Reimers R.G. Haller Inherited defects of muscle energy metabolism: Radiologic evaluation Fleckenstein J.L. Crures J.V. Reimers C.D. Muscle Imaging in Health and Disease 1996 Springer New York 253
32. D. Gadian G. Radda B. Ross Examination of a myopathy by phosphorus nuclear magnetic resonance Lancet 2 1981 774
33. U. Giger Z. Argov M. Schnall Metabolic myopathy in canine muscle-type phosphofructokinase deficiency Muscle Nerve 11 1988 1260
34. Hagspiel K.D. von Weymarn C. G. McKinnon Effect of hypothyroidism on phosphorus metabolism in muscle and liver: In vivo 31 P-MR spectroscopy study J Magn Reson Imaging 2 1992 527
35. R.G. Haller S.F. Lewis Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency N Engl J Med 324 1991 364
36. D.J. Hayes D. Hilton-Jones D.L. Arnold A mitochondrial encephalomyopathy: A combined 31 P magnetic resonance and biochemical investigation J Neurol Sci 71 1985 105
37. T.D. Heiman-Patterson Z. Argov J.M. Chavin Biochemical and genetic studies in a family with mitochondrial myopathy Muscle Nerve 20 1997 1219
38. P. Jehenson A. Leroy-Willig de Kerviler E. MR imaging as a potential diagnostic test for metabolic myopathies: Importance of variations in the T2 of muscle with exercise AJR Am J Roentgenol 161 1993 347
39. K.E. Jensen J. Jakobsen C. Thomsen Improved energy kinetics following high protein diet in McArdle's syndrome: A 31 P magnetic resonance spectroscopy study Acta Neurol Scand 81 1990 499
40. P. Kaminsky B. Robin-Lherbier F. Brunotte Energetic metabolism in hypothyroid skeletal muscle, as studied by phosphorus magnetic resonance spectroscopy J Clin Endocrinol Metab 74 1992 124
41. G.J. Kemp G.K. Radda Quantitative interpretation of bioenergetic data from 31 P and 1H magnetic resonance spectroscopic studies of skeletal muscle: An analytical review Magnetic Resonance Quarterly 10 1994 43
42. G.J. Kemp D.J. Taylor C.H. Thompson Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise NMR Biomed 6 1993 302
43. C.K. Kuhl G. Layer F. Traber Mitochondrial encephalomyopathy: Correlation of P-31 exercise MR spectroscopy with clinical findings Radiology 192 1994 223
44. 1H-MRS study Neurology 44 1994 557
45. S.F. Lewis R.G. Haller J.D. Cook Muscle fatigue in McArdle's disease studied by 31 P-NMR: Effect of glucose infusion J Appl Physiol 59 1985 1991
46. P.M. Matthews C. Allaire E.A. Shoubridge In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease Neurology 41 1991 114
47. P.M. Matthews F. Andermann K. Silver Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies Neurology 43 1993 2484
48. P.M. Matthews S.F. Berkovic E.A. Shoubridge In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF) Ann Neurol 29 1991 435
49. P.M. Matthews R.M. Brown K. Morten Intracellular heteroplasmy for disease-associated point mutations in mtDNA: Implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA Hum Genet 96 1995 261
50. 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease Neurology 43 1993 884
51. P.M. Matthews D. Tampieri S.F. Berkovic Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome Neurology 41 1991 1043
52. P. Montagna P. Martinelli P. Cortelli Brain 31P-magnetic resonance spectroscopy in mitochondrial cytopathies [letter; comment] Ann Neurol 31 1992 451
53. K.J. Morten M. Caky P.M. Matthews Stabilization of the pyruvate dehydrogenase E1α subunit by dichloroacetate Neurology 51 1998 1331
54. E. Najim J.P. Grivet A double-tuned probe for metabolic NMR studies Magn Reson Med 23 1992 367
55. 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin Neurology 42 1992 2147
56. G.K. Radda P.J. Bore D.G. Gadian 31 P-NMR examination of two patients with NADH-CoQ reductase deficiency Nature 295 1982 608
57. 31P nuclear magnetic resonance N Engl J Med 304 1981 1338
58. F.G. Shellock L.L. Tyson J.L. Fleckenstein Diagnostic imaging of skeletal muscle exercise physiology and pathophysiology Fleckenstein J.L. Crures J.V. Reimers C.D. Muscle Imaging in Health and Disease 1996 Springer New York 113
59. P.W. Stacpoole Y.J. Greene Dichloroacetate Diabetes Care 15 1992 785
60. Taivassalo T. De Stefano N. Z. Argov Effects of aerobic training in patients with mitochondrial myopathies Neurology 50 1998 1055
61. T. Taivassalo P.M. Matthews De Stefano N. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency Neurology 47 1996 529
62. M.A. Tarnopolsky G. Parise Intramuscular phosphocreatine and ATP are decreased in patients with dystrophy and inflammatory myopathy [abstract] Muscle Nerve (suppl) 7 1998 139
63. D.J. Taylor G.J. Kemp G.K. Radda Bioenergetics of skeletal muscle in mitochondrial myopathy J Neurol Sci 127 1994 198
64. D.J. Taylor B. Rajagopalan G.K. Radda Cellular energetics in hypothyroid muscle Eur J Clin Invest 22 1992 358